BR9911049A - Terapia combinada para tratamento de depressão resistente - Google Patents

Terapia combinada para tratamento de depressão resistente

Info

Publication number
BR9911049A
BR9911049A BR9911049-0A BR9911049A BR9911049A BR 9911049 A BR9911049 A BR 9911049A BR 9911049 A BR9911049 A BR 9911049A BR 9911049 A BR9911049 A BR 9911049A
Authority
BR
Brazil
Prior art keywords
treatment
combination therapy
resistant depression
activity
compound
Prior art date
Application number
BR9911049-0A
Other languages
English (en)
Inventor
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9911049A publication Critical patent/BR9911049A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Patente de Invenção: <B>"TERAPIA COMBINADA PARA TRATAMENTO DE DEPRESSãO RESISTENTE"<D>. A invenção proporciona métodos e composições para o tratamento de estados depressivos resistentes ao tratamento com terapias antidepressivas tradicionais apenas. Esses métodos e composições empregam um composto tendo atividade como um antipsicótico atípico e um inibidor da recaptação de serotonina. A presente invenção também proporciona métodos para fornecimento de tratamentos com início rápido para uma grande depressão os quais empregam um composto tendo atividade como um antipsicótico atípico e um inibidor da recaptação de serotonina.
BR9911049-0A 1998-05-22 1999-05-21 Terapia combinada para tratamento de depressão resistente BR9911049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8644498P 1998-05-22 1998-05-22
PCT/US1999/011276 WO1999061027A1 (en) 1998-05-22 1999-05-21 Combination therapy for treatment of refractory depression

Publications (1)

Publication Number Publication Date
BR9911049A true BR9911049A (pt) 2001-02-06

Family

ID=22198612

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911049-0A BR9911049A (pt) 1998-05-22 1999-05-21 Terapia combinada para tratamento de depressão resistente

Country Status (24)

Country Link
EP (1) EP0958824A3 (pt)
JP (1) JP2002516282A (pt)
KR (1) KR20010043730A (pt)
CN (1) CN1154496C (pt)
AU (1) AU761510B2 (pt)
BR (1) BR9911049A (pt)
CA (1) CA2332814C (pt)
CZ (1) CZ20004279A3 (pt)
EA (1) EA004539B1 (pt)
HK (1) HK1040055B (pt)
HR (1) HRP20000797A2 (pt)
HU (1) HUP0101901A3 (pt)
ID (1) ID26861A (pt)
IL (1) IL139592A (pt)
MY (1) MY127938A (pt)
NO (1) NO20005885L (pt)
NZ (1) NZ507980A (pt)
PL (1) PL344331A1 (pt)
SK (1) SK17512000A3 (pt)
TR (1) TR200003443T2 (pt)
TW (1) TWI226829B (pt)
UA (1) UA78181C2 (pt)
WO (1) WO1999061027A1 (pt)
ZA (1) ZA200006815B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174882B1 (en) * 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
SI1237553T1 (sl) * 1999-12-06 2006-06-30 Lundbeck & Co As H Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
AU2002232470B2 (en) * 2001-01-02 2005-11-03 Pharmacia & Upjohn Company Llc New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
EP1551393A4 (en) 2002-07-30 2010-06-16 Peter Migaly COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
CN1726039B (zh) 2002-12-27 2010-08-18 大塚制药株式会社 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
BRPI0413750A (pt) * 2003-09-04 2006-10-24 Lundbeck & Co As H uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit
CN103788089A (zh) 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
WO2005053703A1 (en) * 2003-12-02 2005-06-16 Leslie James Sheldon Combination therapy for dementia, depression and apathy
EP1696896A2 (en) * 2003-12-15 2006-09-06 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2007025177A2 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
AR061481A1 (es) 2006-06-16 2008-08-27 Lundbeck & Co As H Compuestos con actividad combinada sobre sert, 5-ht3 y 5-ht1a
JP5467870B2 (ja) * 2007-02-09 2014-04-09 アルファファーム ピーティーワイ リミテッド 異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
TWI432194B (zh) * 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
CN105769875A (zh) * 2014-12-22 2016-07-20 扬子江药业集团上海海尼药业有限公司 复方奥氮平盐酸氟西汀胶囊的制备方法
CN108938645A (zh) * 2018-08-24 2018-12-07 山西医科大学第医院 一种抗精神病药物组合物
CN111084778B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种奥氮平盐酸氟西汀胶囊及其制备方法
CN114569566A (zh) * 2020-12-02 2022-06-03 四川科瑞德制药股份有限公司 一种盐酸米那普仑制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
HUP9903679A3 (en) * 1996-03-11 2001-10-29 Lilly Co Eli Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
US5945416A (en) * 1996-03-25 1999-08-31 Eli Lilly And Company Method for treating pain
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
IL139592A0 (en) 2002-02-10
PL344331A1 (en) 2001-11-05
EP0958824A2 (en) 1999-11-24
JP2002516282A (ja) 2002-06-04
WO1999061027A1 (en) 1999-12-02
ZA200006815B (en) 2002-01-14
EA004539B1 (ru) 2004-06-24
HUP0101901A2 (hu) 2001-11-28
CA2332814C (en) 2008-11-04
AU761510B2 (en) 2003-06-05
HK1040055B (zh) 2005-04-01
SK17512000A3 (sk) 2002-02-05
AU4008699A (en) 1999-12-13
CN1154496C (zh) 2004-06-23
EP0958824A3 (en) 1999-12-01
CA2332814A1 (en) 1999-12-02
KR20010043730A (ko) 2001-05-25
HRP20000797A2 (en) 2001-10-31
CZ20004279A3 (cs) 2001-09-12
NZ507980A (en) 2003-10-31
NO20005885L (no) 2001-01-17
ID26861A (id) 2001-02-15
HUP0101901A3 (en) 2002-06-28
NO20005885D0 (no) 2000-11-21
UA78181C2 (en) 2007-03-15
CN1311681A (zh) 2001-09-05
HK1040055A1 (en) 2002-05-24
TR200003443T2 (tr) 2001-03-21
EA200001218A1 (ru) 2001-06-25
IL139592A (en) 2005-08-31
MY127938A (en) 2007-01-31
TWI226829B (en) 2005-01-21

Similar Documents

Publication Publication Date Title
BR9911049A (pt) Terapia combinada para tratamento de depressão resistente
BR9911068A (pt) Terapia combinada para tratamento de distúrbios bipolares
BR0213975A (pt) Métodos para tratar doenças neovasculares oculares
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
BR0013122A (pt) Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
BR0310092A (pt) Combinação de compostos orgânicos
MY134110A (en) Combinations of reboxetine and neuroleptic agents
BR0212611A (pt) Compostos de pirazolila substituìdos para o tratamento da inflamação
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
BR9812122A (pt) Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata
BR9913288A (pt) Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
EA200501601A1 (ru) Соединения 1,2,4-оксадиазолбензойной кислоты и их применение
UY28945A1 (es) Derivados de pirrolopiridina
ES2137456T3 (es) Agente de tratamiento de las enfermedades hepato-biliares.
PA8493701A1 (es) Compuestos para tratar la obesidad
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
ATE538801T1 (de) Therapeutische zusammensetzungen mit mindestens einem pyrrolobenzodiazepin-derivat und fludarabin
BRPI0414794A (pt) oxadiazolidinadionas substituìdas
MY152919A (en) Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
BR0312845A (pt) Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BR0208405A (pt) Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças
BRPI0411665A (pt) uso de agomelatina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica ou kit, e, métodos para o tratamento de doenças ou distúrbios responsivos a um inibidor da recaptação de serotonina e para aumentar e/ou proporcionar inìcio mais rápido do efeito terapêutico de um inibidor da recaptação de serotonina
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/5513, A61K 31/137, A61P 25/24

Ipc: A61K 31/5513 (2007.10), A61K 31/137 (2007.10), A61

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO O PRESENTE PEDIDO, UMA VEZ QUE NAO ESTA DE ACORDO COM O ARTIGO 8O, ART.11 E ART. 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.